Simcor

Abbott sells a combination of Niaspan and simvastatin called Simcor.

BusinessWeek.com -- Top News 2011

North Chicago-based Abbott Laboratories recently launched its combination pill known as Simcor, a pairing of Niaspan, a pill that raises HDL, the so-called good cholesterol, and generic Zocor, a drug in a class known as statins that lower LDL, the bad cholesterol.

Impact Lab 2008

Simvastatin is available in many generic versions and is part of the combination product Vytorin, also sold by Merck, and Simcor, marketed by Abbott Laboratories .

FDA Urges Limits on Dosages of Zocor Jennifer Corbett Dooren 2011

Simvastatin is available in many generic versions and is part of the combination product Vytorin, also sold by Merck, and Simcor, marketed by Abbott Laboratories .

FDA Urges Limits on Dosages of Zocor Jennifer Corbett Dooren 2011

FDA Clears Cholesterol Drug The Food and Drug Administration granted Abbott Labs approval for Simcor, an anticipated blockbuster drug that raises "good" cholesterol and lowers both "bad" cholesterol and triglycerides.

Less Buy 2008

Abbott, of Abbott Park, Ill., said it is conducting a study investigating whether Simcor is better than simvastatin or Niaspan alone, but results won't be available until 2011.

FDA Clears Abbott's Combination Heart Drug 2008

In its cholesterol franchise, which includes niacin-based drugs such as Niaspan and Simcor, and the fenofibrate TriCor, the company's growth outpaced the rest of the cholesterol-drug market, Morgan Stanley analyst Glenn Reicin said.

Abbott Posts Growth in All Sectors 2008

Simcor is a combination of two existing, approved treatments: simvastatin, a statin, and Abbott's Niaspan, an extended-release version of niacin, a B vitamin.

FDA Clears Abbott's Combination Heart Drug 2008

Mr. Fante added that Crestor will be promoted only by Abbott staffers who aren't already selling the Abbott Park, Ill., company's recently launched Simcor cholesterol treatment.

AstraZeneca, Abbott in Cholesterol-Drug Pact 2008

Abbott said conversations about partnering with AstraZeneca began well before Simcor hit the market.

AstraZeneca, Abbott in Cholesterol-Drug Pact 2008